texas oncology more breakthroughs. more victories
I am a: Patient | Caregiver | Refering Physician

Tarrik M. Zaid, M.D., M.Sc.

Education

  • Fellowship in Gynecologic Oncology,
    The University of Texas MD Anderson Cancer Center, Houston, TX
  • Fellowship in Gynecologic Oncology (Felix Rutledge Fellow),
    The University of Texas MD Anderson Cancer Center, Houston, TX
  • Fellowship in Gynecologic Oncology (Galloway Fellowship),
    Memorial Sloan Kettering Cancer Center, New York, NY
  • Residency in Obstetrics & Gynecology,
    The University of Mississippi Medical Center, Winfred L. Wiser Hospital for Women and Infants, Jackson, MS
  • Bachelor of Medicine and Bachelor of Surgery (BM, BCh),
    Faculty of Medicine, Health Sciences Center - Kuwait University, Kuwait City, Kuwait (June 2001 - June 2004) Graduated with First Class Honors
  • Bachelor of Medical Science (BMedSc),
    Faculty of Meicine, Health Science Center Center - Kuwait University, Kuwait City, Kuwait (June 1997 - June 2001) Graduated with First Class Honor

Surgery Locations

  • Houston Methodist Sugar Land
    16655 Southwest Fwy,
    Sugar Land, TX 77479
  • Memorial Hermann Sugar Land
    17500 W Grand Pkwy S,
    Sugar Land, TX 77479

Conditions

  • Uterine cancer (Endometrial)
  • Endometrial hyperplasia and endometrial intraepithelial neoplasia
  • Ovarian cancer
  • Cervical cancer
  • Cervical dysplasia
  • Peritoneal cancer
  • Vulvar/Vaginal cancer
  • Vulvar and vaginal dysplasia

Other conditions

  • Gestational Trophoblastic Disease
  • Gynecological Sarcomas
  • Complex Benign Gynecological Conditions

Procedures

Uterine cancer (Endometrial), Radical Robotic Procedures
  • Laparoscopic/Robotic assisted laparoscopic hysterectomy / Bilateral salpingo-oophorectomy (BSO)
  • Robotic radical hysterectomy / BSO
  • Laparoscopic/Robotic assisted Lymphadenectomy / Sentinel Lymph Node (SLN) Mapping
  • Fertility-sparing approach
  • Endometrial hyperplasia and endometrial intraepithelial neoplasia
Ovarian cancer
  • Cytoreductive Surgery (Debulking)
  • Interval Robotic Laparoscopic cytoreductive surgery
  • Ovarian cancer cytoreductive surgery (Laparotomy)
Cervical cancer
  • Colposcopy
  • Cervical dysplasia – laser ablation, Cold Knife Cone/LEEP/ECC
  • Robotic radical hysterectomy
  • Fertility sparing approach
Peritoneal cancer
  • Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastrointestinal Malignancies
Vulvar/Vaginal cancer
  • Simple and Radical vulvectomy
  • CO2 laser ablation of vulvar and vaginal dysplasia
  • Sentinel Lymph Node (SLN) Mapping
  • Vaginectomy

Other procedures

  • Robotic malignancy staging
  • Robotic laparoscopic pelvic SLN
  • Tumor debulking for gynecologic malignancies
  • Cytoreductive surgery
  • Advanced pelvic surgery

Additional Training

  • Master of Science, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences, Houston, TX (July 2009-August 2011)
  • International Certificate of Secondary Education, University of Cambridge, Cambridge, United Kingdom (June 1996-June 1997)

Accolades & Memberships

  • Annual Meeting Merit Award, American Society of Clinical Oncology (2011)
  • Resident Scholar Award, Association of Professors of Gynecology & Obstetrics (2008)
  • The John Kitching’s Council on Resident Education in Obstetrics and Gynecology Award, The University of Mississippi Medical Center (2006-2009)
  • Award for Outstanding Performance in the Bachelor of Medical Science Program, Health Sciences Centre - Kuwait University (2004)
  • Academic Excellence Award, The Kuwait Medical Students Association (2004)
  • Academic Excellence Award, The Kuwait Medical Students Association (2003)
  • Best Undergraduate Research Poster (8th Annual Health Science Center Poster Day), Health Sciences Center - Kuwait University (2003)
  • Academic Excellence Award, The Kuwait Medical Students Association (2002)
  • Dean’s Honors Society (Faculty of Medicine), Health Sciences Center - Kuwait University (1997-2004)
  • Fellow, American College of Obstetricians and Gynecologists (July 2005-Present)
  • Member, Society of Gynecologic Oncology (July 2009-Present)
  • Member, American Society of Clinical Oncology (July 2009-Present)
  • Member, American Association for Cancer Research (July 2009-Present)

Research Interest

  • NRG Oncology/Gynecologic Oncology Group (GOG) Site Principal Investigator, Houston Methodist Sugar Land Hospital (2014-Present)
  • Co-investigator, The University of Texas MD Anderson Cancer (May 2012-June 2013) Institutional Review Board (IRB) Exempt protocol: Use of Social Media as a Platform for Research Involving Rare Gynecologic Tumors
  • Co-investigator, The University of Texas MD Anderson Cancer Center (May 2012-June 2013) IRB protocol PA12-Clinicopathologic Characteristics of Epithelial Ovarian Carcinoma at the Time of Interval Surgical Cytoreduction with Emphasis on Pathologic Status of the Hysterectomy Specimen
  • Master’s degree thesis, The University of Texas MD Anderson Cancer Center UTHealth Houston Graduate School of Biomedical Sciences (July 2009-July 2011) The Role of Acidic Fibroblast Growth Factor and Fibroblast Growth Factor Receptor 4 In High Grade Serous Carcinoma. Supervisor Dr. S. Mok Department of Gynecologic Oncology, University of Texas MD Anderson Cancer Center. This study was supported in part by grants R01 CA133057 (S.C. Mok) SPORE grant P50 CA083639 (S.C. Mok) from the National Institutes of Health.
  • Co-investigator, University of Mississippi Medical Center, (July 2005-June 2009) IRB protocol # 2003-0065: The Effect of Clomiphene Citrate vs Letrazole on the Luteal Endometrium. Division of Reproductive Endocrinology, Department of Ob-Gyn, University of Mississippi Medical Center
  • Co-investigator, University of Mississippi Medical Center (November 2005-June 2009) IRB protocol # 2006-0231: A Randomized Prospective Trial of Tape Closure and Suture Closure in Superficial Wound Dehiscence. Division of Gynecology, Department of Ob-Gyn, University of Mississippi Medical Center
  • Co-investigator, University of Mississippi Medical Center (July 2005-June 2009) IRB protocol # 2006-0205: Molecular Analysis of Uterine Fibroids. Division of Gynecology, Department of Ob-Gyn, University of Mississippi Medical Center
  • Research Assistant, Health Sciences Center - Kuwait University (2004-May 2005) IRB protocol # KU-416: Expression Patterns of Apolipoprotein E Isoforms in Multiple Sclerosis and Schizophrenia. Division of Clinical Chemistry, Department of Pathology, Kuwait University College of Medicine
  • Research Assistant, Health Sciences Center - Kuwait University (June 1999-June 2003) Grant KU 4496: Therapeutic potential of intermittent pneumatic compression in the treatment of osteomyelitis. Department of Nuclear Medicine, Kuwait University College of Medicine
  • Research Coordinator, Health Sciences Center - Kuwait University (September 2000-September 2003) IRB exempt protocol - Risk Behaviors Among Medical Students in Selected Countries in the East Mediterranean Region. World Health Organization (WHO) Regional Office for the Eastern Mediterranean, Cairo, Egypt
  • Principal Investigator, Health Sciences Center - Kuwait University (June 2002-June 2003) IRB exempt protocol - Psychological and Sociodemographic Correlates of Glycemic Control in Patients with Type 2 Diabetes Mellitus. Epidemiology Course Project, Department of Community Medicine and Epidemiology, Kuwait University College of Medicine
  • Summer Research Intern, Kuwait University College of Medicine (June 2001-September 2001) Grant MB031: Expression of catalase and catalase related genes in E.coli. Oxidative Biology Laboratory, Department of Biochemistry, Kuwait University College of Medicine